Walgreens Boots Alliance, Inc. (WBA) EPS Estimated At $1.55

March 18, 2018 - By Nellie Frank

 Walgreens Boots Alliance, Inc. (WBA) EPS Estimated At $1.55

Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to report $1.55 EPS on March, 28 before the open.They anticipate $0.19 EPS change or 13.97 % from last quarter’s $1.36 EPS. WBA’s profit would be $1.54 billion giving it 10.90 P/E if the $1.55 EPS is correct. After having $1.28 EPS previously, Walgreens Boots Alliance, Inc.’s analysts see 21.09 % EPS growth. The stock increased 0.28% or $0.19 during the last trading session, reaching $67.57. About 10.31 million shares traded or 85.67% up from the average. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has risen 5.77% since March 18, 2017 and is uptrending. It has underperformed by 10.93% the S&P500.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Coverage

Among 22 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 13 have Buy rating, 1 Sell and 8 Hold. Therefore 59% are positive. Walgreens Boots Alliance had 55 analyst reports since August 24, 2015 according to SRatingsIntel. The rating was upgraded by Cowen & Co on Wednesday, September 9 to “Outperform”. The rating was maintained by Loop Capital Markets on Tuesday, February 13 with “Buy”. On Wednesday, October 28 the stock rating was upgraded by RBC Capital Markets to “Buy”. Jefferies maintained it with “Buy” rating and $95.0 target in Tuesday, September 5 report. The rating was upgraded by Zacks to “Hold” on Tuesday, September 1. The company was downgraded on Friday, July 22 by Wood. Needham maintained Walgreens Boots Alliance, Inc. (NASDAQ:WBA) on Monday, July 17 with “Buy” rating. The stock has “Buy” rating by Zacks on Monday, August 24. The firm has “Buy” rating given on Thursday, October 29 by S&P Research. Robert W. Baird initiated the shares of WBA in report on Friday, January 22 with “Outperform” rating.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company has market cap of $66.94 billion. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. It has a 18.64 P/E ratio. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: